Free CCEP Practice Test

The CCEP exam spans 8 domains - Basic Physiology, Anatomy, Pharmacology, and Genetics (20%) — Cellular electrophysiology (4%): action potentials, ion channels and currents, receptors, gap junctions; Cardiac anatomy (≤2%); Cardiac tissue physiology (10%): refractory periods, neuronal control—sympathetic nervous system and catecholamines, atrioventricular (AV) and ventriculoatrial (VA) conduction delay and block, mechanisms of arrhythmias, electrical and structural remodeling, repolarization—dispersion and reserve, other physiologic phenomena (retrograde block, ACE inhibitors, fractionated electrograms, pseudonormalization); Pharmacology (4%): pharmacokinetics, use and reverse use dependence, properties of antiarrhythmic agents; Genetics (≤2%): ion channels, non-ion channels., Clinical Arrhythmias: Core Concepts (5%) — Recognition of artifact (≤2%); pacing, signal recording, and mapping systems (electrophysiology laboratory) (≤2%); noninvasive testing (≤2%): indications, tilt-table testing, interpretation of wide QRS tachycardias, ambulatory electrocardiographic monitoring; invasive electrophysiologic testing (2%): indications, interpretation; biophysics of ablation (≤2%); transseptal catheterization and pericardial access (≤2%); cardiac and intracardiac imaging (≤2%)., Clinical Arrhythmias: Bradycardias (5%) — Sinus node dysfunction (≤2%); AV block (3%): AV nodal block, infranodal AV block; escape and accelerated rhythms (≤2%)., Clinical Arrhythmias: Atrial (12%) — Atrial fibrillation (5%): mechanism and etiology, ECG monitors and remote monitoring, pharmacologic treatment, postoperative atrial fibrillation, stroke prevention, cardioversion, catheter ablation, surgical ablation, AV junction ablation; Atrial flutter (4%): ECG monitors and remote monitoring, pharmacologic treatment, stroke prevention, cardioversion, cavotricuspid isthmus (CTI)-dependent atrial flutter, atypical right atrial flutter, atypical left atrial flutter; Focal atrial tachycardias (3%): ECG monitors and remote monitoring, pharmacologic treatment, catheter ablation., Clinical Arrhythmias: Supraventricular Tachycardias (15%) — Accessory pathway syndromes (9%): ECG monitors and remote monitoring, pharmacologic treatment, electrophysiologic studies in ventricular preexcitation, electrophysiologic studies in orthodromic AVRT (typical and atypical pathways), electrophysiologic studies in antidromic AVRT (typical and atypical pathways), ablation of accessory pathways, fasciculoventricular pathways, multiple pathways; AV nodal reentry tachycardia (AVNRT) (5%): typical AVNRT (ECGs, pharmacologic treatment, intracardiac recordings, and ablation), atypical AVNRT (ECGs, pharmacologic treatment, intracardiac recordings, and ablation); Junctional tachycardias (≤2%): ECG monitors and remote monitoring, pharmacologic treatment, interpretation of electrophysiology recordings, ablation; Multiple SVT mechanisms (≤2%): ECG monitors and remote monitoring, pharmacologic treatment, interpretation of electrophysiology recordings, ablation., Clinical Arrhythmias: Ventricular (15%) — ECGs and ambulatory monitoring (3%): ambulatory monitor recordings, ECG localization—premature ventricular complexes (PVC) and VT; Core concepts (5%): indications for invasive electrophysiologic studies, interpretation of intracardiac recordings, pharmacologic treatment, principles of entrainment; Ventricular tachycardias and ischemic heart disease (3%): physiology, endocardial ablation, epicardial ablation, arrhythmias in patients with a left ventricular assist device (LVAD), hemodynamic support during ablation; Ventricular tachycardias and nonischemic cardiomyopathy (≤2%): physiology, endocardial ablation, epicardial ablation, arrhythmias in patients with a left ventricular assist device (LVAD), hemodynamic support during ablation; Ventricular tachycardias and premature ventricular complexes and the normal heart (2%): physiology, endocardial ablation, epicardial ablation; Ventricular fibrillation and polymorphic ventricular tachycardias (≤2%): physiology, ECG monitors and remote monitoring, pharmacologic treatment, bradycardia-dependent, drug-induced, ischemic, indications for invasive electrophysiologic studies, ablation., Devices (20%) — General concepts (≤2%): electromagnetic interference, biophysics and bioengineering, lead extraction, infection, automatic external and wearable defibrillators; Pacemakers (6%): indications, implantation techniques, programming and follow-up, complications, leadless pacing; Implantable cardioverter-defibrillator (ICD) therapy (7%): indications, implantation techniques, ECG monitors and remote monitoring, programming, follow-up, complications, subcutaneous implantable defibrillator; Cardiac resynchronization (5%): indications, implantation techniques, ECG monitors and remote monitoring, programming, leads, follow-up, complications; Insertable loop recorders (≤2%)., and Clinical Scenarios and Syndromes (8%) — Common scenarios (2%): syncope, palpitations, sudden cardiac death, ethics, manage advisories and recalls; Specific syndromes (6%): long QT syndrome, Brugada syndrome, catecholaminergic polymorphic VT, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, sarcoidosis, other arrhythmia substrates (musculoskeletal, short QT syndrome, early repolarization syndrome), arrhythmias in pregnancy, arrhythmias in athletes, congenital heart disease.. Every practice question maps to one of them, so you train on exactly what's tested.

Every paid plan unlocks the full bank of 1,000+ practice questions covering all 8 CCEP domains - Basic Physiology, Anatomy, Pharmacology, and Genetics (20%) — Cellular electrophysiology (4%): action potentials, ion channels and currents, receptors, gap junctions; Cardiac anatomy (≤2%); Cardiac tissue physiology (10%): refractory periods, neuronal control—sympathetic nervous system and catecholamines, atrioventricular (AV) and ventriculoatrial (VA) conduction delay and block, mechanisms of arrhythmias, electrical and structural remodeling, repolarization—dispersion and reserve, other physiologic phenomena (retrograde block, ACE inhibitors, fractionated electrograms, pseudonormalization); Pharmacology (4%): pharmacokinetics, use and reverse use dependence, properties of antiarrhythmic agents; Genetics (≤2%): ion channels, non-ion channels., Clinical Arrhythmias: Core Concepts (5%) — Recognition of artifact (≤2%); pacing, signal recording, and mapping systems (electrophysiology laboratory) (≤2%); noninvasive testing (≤2%): indications, tilt-table testing, interpretation of wide QRS tachycardias, ambulatory electrocardiographic monitoring; invasive electrophysiologic testing (2%): indications, interpretation; biophysics of ablation (≤2%); transseptal catheterization and pericardial access (≤2%); cardiac and intracardiac imaging (≤2%)., Clinical Arrhythmias: Bradycardias (5%) — Sinus node dysfunction (≤2%); AV block (3%): AV nodal block, infranodal AV block; escape and accelerated rhythms (≤2%)., Clinical Arrhythmias: Atrial (12%) — Atrial fibrillation (5%): mechanism and etiology, ECG monitors and remote monitoring, pharmacologic treatment, postoperative atrial fibrillation, stroke prevention, cardioversion, catheter ablation, surgical ablation, AV junction ablation; Atrial flutter (4%): ECG monitors and remote monitoring, pharmacologic treatment, stroke prevention, cardioversion, cavotricuspid isthmus (CTI)-dependent atrial flutter, atypical right atrial flutter, atypical left atrial flutter; Focal atrial tachycardias (3%): ECG monitors and remote monitoring, pharmacologic treatment, catheter ablation., Clinical Arrhythmias: Supraventricular Tachycardias (15%) — Accessory pathway syndromes (9%): ECG monitors and remote monitoring, pharmacologic treatment, electrophysiologic studies in ventricular preexcitation, electrophysiologic studies in orthodromic AVRT (typical and atypical pathways), electrophysiologic studies in antidromic AVRT (typical and atypical pathways), ablation of accessory pathways, fasciculoventricular pathways, multiple pathways; AV nodal reentry tachycardia (AVNRT) (5%): typical AVNRT (ECGs, pharmacologic treatment, intracardiac recordings, and ablation), atypical AVNRT (ECGs, pharmacologic treatment, intracardiac recordings, and ablation); Junctional tachycardias (≤2%): ECG monitors and remote monitoring, pharmacologic treatment, interpretation of electrophysiology recordings, ablation; Multiple SVT mechanisms (≤2%): ECG monitors and remote monitoring, pharmacologic treatment, interpretation of electrophysiology recordings, ablation., Clinical Arrhythmias: Ventricular (15%) — ECGs and ambulatory monitoring (3%): ambulatory monitor recordings, ECG localization—premature ventricular complexes (PVC) and VT; Core concepts (5%): indications for invasive electrophysiologic studies, interpretation of intracardiac recordings, pharmacologic treatment, principles of entrainment; Ventricular tachycardias and ischemic heart disease (3%): physiology, endocardial ablation, epicardial ablation, arrhythmias in patients with a left ventricular assist device (LVAD), hemodynamic support during ablation; Ventricular tachycardias and nonischemic cardiomyopathy (≤2%): physiology, endocardial ablation, epicardial ablation, arrhythmias in patients with a left ventricular assist device (LVAD), hemodynamic support during ablation; Ventricular tachycardias and premature ventricular complexes and the normal heart (2%): physiology, endocardial ablation, epicardial ablation; Ventricular fibrillation and polymorphic ventricular tachycardias (≤2%): physiology, ECG monitors and remote monitoring, pharmacologic treatment, bradycardia-dependent, drug-induced, ischemic, indications for invasive electrophysiologic studies, ablation., Devices (20%) — General concepts (≤2%): electromagnetic interference, biophysics and bioengineering, lead extraction, infection, automatic external and wearable defibrillators; Pacemakers (6%): indications, implantation techniques, programming and follow-up, complications, leadless pacing; Implantable cardioverter-defibrillator (ICD) therapy (7%): indications, implantation techniques, ECG monitors and remote monitoring, programming, follow-up, complications, subcutaneous implantable defibrillator; Cardiac resynchronization (5%): indications, implantation techniques, ECG monitors and remote monitoring, programming, leads, follow-up, complications; Insertable loop recorders (≤2%)., and Clinical Scenarios and Syndromes (8%) — Common scenarios (2%): syncope, palpitations, sudden cardiac death, ethics, manage advisories and recalls; Specific syndromes (6%): long QT syndrome, Brugada syndrome, catecholaminergic polymorphic VT, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, sarcoidosis, other arrhythmia substrates (musculoskeletal, short QT syndrome, early repolarization syndrome), arrhythmias in pregnancy, arrhythmias in athletes, congenital heart disease.. You can practice the whole bank, filter by domain, or run a timed, domain-balanced exam simulation.

Yes. You get 10 free sample questions with instant feedback - no credit card and no account required.

No. Every plan is a single one-time payment for a fixed access window - 48 hours, 7 days, or 6 weeks. There is no auto-renewal and no recurring billing.

Yes - the whole platform is mobile-first: practice, mistake review, and analytics all work on any phone, tablet, or laptop with a browser. Nothing to install.